EXOZ: Rega marang dodolan Invizyne

Tandha merek Invizyne (EXOZ)

The price-to-sales ratio dynamics show that the current parameter equals . High laboratory costs at eXoZymes Inc (EXOZ) create a significant burden prior to the commercialization stage. The efficiency of complex molecule synthesis allows for the reduction of production costs. Meanwhile, the company relies on licensing and cloud computing to develop AI algorithms, outsourcing mass production to external contractors.

EXOZ (Invizyne Technologies, Inc.) riwayat Rasio rega marang pendapatan saka 04.07.2022 nganti 13.11.2026

Invizyne Technologies, Inc. (EXOZ) - rincian metrik lan laporan keuangan

- rega saham lan konsensus proyeksi valuasi:
Bagan owah-owahan rega invizyne.com|EXOZ - Prakiraan konsensus analis
- informasi kapitalisasi pasar:
Nilai pasar Invizyne Technologies, Inc.|EXOZ - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- data nilai buku modal saham:
Ekuitas saben Saham eXoZymes|EXOZ - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku invizyne.com|EXOZ - Gunggung Aset Perusahaan
- rincian struktur utang lan likuiditas bisnis:
Utang Agregat marang Ekuitas eXoZymes Inc|EXOZ - Rasio utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Invizyne|EXOZ - Utang perusahaan|Utang marang nilai buku Invizyne Technologies, Inc.|EXOZ - Utang jangka dawa perusahaan|Utang jangka cendhak eXoZymes|Koefisien jangkoan perantara invizyne.com
- indikator pendapatan resik lan kelipatan nilai:
EXOZ - Penghasilan resik|Penghasilan resik sing dikarepake eXoZymes Inc|EXOZ - Pangali P/E|Kapitalisasi marang proyeksi bathi Invizyne Technologies|EXOZ - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Invizyne Technologies, Inc.|EXOZ - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan eXoZymes|EXOZ - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan invizyne.com|EXOZ - Wutah bathi resik saben saham ing taun iki|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep eXoZymes Inc
- data total pendapatan lan volume dodolan:
EXOZ - Pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan invizyne.com|EXOZ - Kapitalisasi marang pendapatan|Rega mangsa ngarep marang pendapatan Invizyne Technologies, Inc.
Analisis fundamental perusahaan:EXOZ (invizyne.com)
Barang unggulan eXoZymes

The ratio of market capitalization to annual sales allows for the determination of the premium paid for a business by measuring the company's value through the prism of its actual revenue. By analyzing the price-to-sales ratio dynamics, an investor can assess the resilience of eXoZymes Inc. (EXOZ) to geopolitical risks and sanctions, which restrict access to raw materials and reduce the overall profitability of biocatalyst production.

Perusahaan pesaing

HLN (haleon.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S KVUE (Kenvue)|Verona Pharma PLC (VRNA) - Rega marang dodolan|MENS: Kapitalisasi marang pendapatan|LGND (Ligand Corp) - Rasio kapitalisasi marang pendapatan|Amneal Pharmaceuticals (AMRX) - Rasio rega marang pendapatan|Rega marang dodolan perrigo.com (PRGO)|Kapitalisasi marang pendapatan ALVO|Liquidia Corp - Rasio rega marang dodolan|Kapitalisasi marang pendapatan GLPG (Galapagos Genomics)|ANIP - Rega marang dodolan|Rasio rega marang pendapatan MannKind Corporation MNKD|AMPH - Kapitalisasi marang pendapatan|Pacira BioSciences, Inc. - Multiplikator P/S|Rega marang dodolan ARS Pharmaceuticals Inc|Theravance (TBPH) - Rasio rega marang pendapatan|AQST - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan SCPH|TECX: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S TNXP|Koefisien rega marang pendapatan sxtchina.com|Rasio rega marang pendapatan Eupraxia Pharmaceuticals Inc. EPRX|BHST: Rasio kapitalisasi marang pendapatan|Oramed Pharma - Multiplikator P/S|Entera Bio Ltd. (ENTX) - Kapitalisasi marang pendapatan|HYFT: Multiplikator P/S|Rega marang dodolan ABVC BioPharma Inc. (ABVC)|Kapitalisasi marang pendapatan CPIX|Rasio kapitalisasi marang pendapatan QNTM (Quantum BioPharma Corp)|Rasio rega marang pendapatan FibroGen, Inc. (FGEN)|TELO - Rega marang dodolan|Rani Therapeutics Holdings, Inc. - Kapitalisasi marang pendapatan|SNYR (Synergy CHC Corp.) - Rasio rega marang dodolan|RLYB - Rasio rega marang pendapatan|Rasio rega marang dodolan LEXX|PULM: Multiplikator P/S|Pheton Holdings - Rasio kapitalisasi pasar marang pendapatan|APM (Aptorum Group Ltd) - Multiplikator P/S|Multiplikator P/S Lyra Therapeutics Inc.|Rasio rega marang pendapatan Impact BioMedical (IBO)|TNFA (tnfpharma.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan cbdMD YCBD|PRFX - Kapitalisasi marang pendapatan|Auris Medical - Multiplikator P/S|LIPO - Multiplikator P/S|OPTN (Optinose) - Kapitalisasi marang pendapatan|Pieris Pharma - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Procaps Group S.A.|Rega marang dodolan petrospharma.com PTPI|Kapitalisasi marang pendapatan QLI (Qilian International Holding)|Kapitalisasi marang volume dodolan SLRN|Multiplikator P/S TFFP (TFF Pharma)